Citation: J. Rosenau et al., Lamivudine and low-dose hepatitis B immune globulin for prophylaxis of hepatitis B reinfection after liver transplantation - possible role of mutations in the YMDD motif prior to transplantation as a risk factor for reinfection, J HEPATOL, 34(6), 2001, pp. 895-902
Citation: Hl. Tillmann et Mp. Manns, GB virus-C infection in patients infected with the human immunodeficiency virus, ANTIVIR RES, 52(2), 2001, pp. 83-90
Authors:
Widjaja, A
Wedemeyer, H
Tillmann, HL
Horn, R
Ockenga, J
Jaeckel, E
von zur Muhlen, A
Manns, MP
Brabant, G
Citation: A. Widjaja et al., Hepatitis C and the leptin system - Bound leptin levels are elevated in patients with hepatitis C and decrease during antiviral therapy, SC J GASTR, 36(4), 2001, pp. 426-431
Authors:
Kubicka, S
Rudolph, KL
Hanke, M
Tietze, MK
Tillmann, HL
Trautwein, C
Manns, M
Citation: S. Kubicka et al., Hepatocellular carcinoma in Germany: a retrospective epidemiological studyfrom a low-endemic area, LIVER, 20(4), 2000, pp. 312-318
Citation: Ct. Bock et al., The enhancer I core region contributes to the replication level of hepatitis B virus in vivo and in vitro, J VIROLOGY, 74(5), 2000, pp. 2193-2202
Authors:
Bock, CT
Tillmann, HL
Manns, MP
Trautwein, C
Citation: Ct. Bock et al., The pre-S region determines the intracellular localization and appearance of hepatitis B virus, HEPATOLOGY, 30(2), 1999, pp. 517-525
Authors:
Tillmann, HL
Trautwein, C
Bock, T
Boker, KHW
Jackel, E
Glowienka, M
Oldhafer, K
Bruns, I
Gauthier, J
Condreay, LD
Raab, HR
Manns, MP
Citation: Hl. Tillmann et al., Mutational pattern of hepatitis B virus on sequential therapy with famciclovir and lamivudine in patients with hepatitis B virus reinfection occurring under HBIg immunoglobulin after liver transplantation, HEPATOLOGY, 30(1), 1999, pp. 244-256
Authors:
Wedemeyer, H
Boker, KHW
Pethig, K
Petzold, DR
Flemming, P
Tillmann, HL
Vollmar, J
Basturk, M
Goldmann, E
Griffin, KE
Haverich, A
Manns, MP
Citation: H. Wedemeyer et al., Famciclovir treatment of chronic hepatitis B in heart transplant recipients: A prospective trial, TRANSPLANT, 68(10), 1999, pp. 1503-1511
Authors:
Ascione, A
De Luca, M
Canestrini, C
Di Costanzo, GG
Raimondo, G
Longo, G
Manns, MP
Tillmann, HL
Forte, GB
Rocco, P
Biceglia, O
Faleo, D
Vinelli, F
Cela, EM
Amitrano, L
Addario, L
Gigliotti, T
Citation: A. Ascione et al., Efficacy of high dose of recombinant alpha 2b interferon on long term response in chronic hepatitis C and cirrhosis: prospective randomized multicentre study, ITAL J GAST, 30(5), 1998, pp. 517-523
Authors:
Rambusch, EG
Nashan, B
Tillmann, HL
Boker, KHW
Schlitt, HJ
Maschek, H
Raab, R
Manns, MP
Citation: Eg. Rambusch et al., Hepatitis B de-novo infection following liver transplantation indicating the need for active hepatitis B immunization of liver transplant candidates, Z GASTROENT, 36(12), 1998, pp. 1027-1035